Table 3.
z Scores of pQCT Parameter (Site) | Patient 1 |
Patient 3 |
Patient 5 |
|||
---|---|---|---|---|---|---|
Pretreatment (15 y) | After 4 y of Zoledronate | Pretreatment (15 y) | After 1 y of Zoledronate | 3.5 y After End of Therapy | Pretreatment (10 y) | |
Total density (4%) | −0.4 | −2.9 | −1.9 | 0.0 | −3.9 | 0.8 |
Trabecular density (4%) | 1.5 | −1.6 | −0.6 | 3.0 | −3.1 | −0.9 |
Cortical density (66%) | −4.3 | −4.9 | −4.9 | −3.1 | −2.5 | −3.7 |
Cortical thickness (66%) | −2.3 | −1.0 | −1.1 | 2.3 | −0.1 | −2.3 |
BMC (66%) | −1.7 | 0.0 | −0.9 | −0.5 | −1.4 | −0.3 |
Muscle area (66%) | 3.7 | −1.6 | −1.1 | −1.4 | −1.1 | −1.4 |
Abbreviation: BMC, bone mineral content.